{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T22:28:14Z","timestamp":1782512894331,"version":"3.54.5"},"reference-count":65,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Discovery Today"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.drudis.2022.103355","type":"journal-article","created":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T08:12:29Z","timestamp":1662970349000},"page":"103355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Nanomedicine approaches to reduce cytokine storms in severe infections"],"prefix":"10.1016","volume":"27","author":[{"given":"Mohd","family":"Ahmar Rauf","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Nisar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hosam","family":"Abdelhady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navnath","family":"Gavande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun K.","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.drudis.2022.103355_b0005","doi-asserted-by":"crossref","first-page":"2754","DOI":"10.1182\/blood.V95.9.2754.009k25_2754_2759","article-title":"The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation","volume":"95","author":"Hill","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.drudis.2022.103355_b0010","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(20)30628-0","article-title":"COVID-19: consider cytokine storm syndromes and immunosuppression","volume":"395","author":"Mehta","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.drudis.2022.103355_b0015","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1073\/pnas.0308001101","article-title":"Human and avian influenza viruses target different cell types in cultures of human airway epithelium","volume":"101","author":"Matrosovich","year":"2004","journal-title":"Proceedings of the National Academy of Sciences USA"},{"key":"10.1016\/j.drudis.2022.103355_b0020","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s13054-017-1882-z","article-title":"Recombinant human ACE2: acing out angiotensin II in ARDS therapy","volume":"21","author":"Zhang","year":"2017","journal-title":"Crit Care"},{"key":"10.1016\/j.drudis.2022.103355_b0025","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1186\/s13287-020-01804-6","article-title":"Mesenchymal stem cells: current clinical progress in ARDS and COVID-19","volume":"11","author":"Xiao","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.drudis.2022.103355_b0030","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s41232-020-00131-w","article-title":"Macrophage activation syndrome and COVID-19","volume":"40","author":"Otsuka","year":"2020","journal-title":"Inflamm Regen"},{"key":"10.1016\/j.drudis.2022.103355_b0035","series-title":"Nanomedicine: Design and Applications of Magnetic Nanomaterials, Nanosensors and Nanosystems","author":"Varadan","year":"2008"},{"key":"10.1016\/j.drudis.2022.103355_b0040","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1021\/acs.chemrev.5b00148","article-title":"Nanochemistry and nanomedicine for nanoparticle-based diagnostics and therapy","volume":"116","author":"Chen","year":"2016","journal-title":"Chem Rev"},{"key":"10.1016\/j.drudis.2022.103355_b0045","first-page":"2563","article-title":"Cytokines and chemokines: at the crossroads of cell signalling and inflammatory disease. Biochimica et Biophysica Acta (BBA) - Molecular","volume":"1843","author":"Turner","year":"2014","journal-title":"Cell Res"},{"key":"10.1016\/j.drudis.2022.103355_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102554","article-title":"Convalescent plasma in Covid-19: possible mechanisms of action","volume":"19","author":"Rojas","year":"2020","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.drudis.2022.103355_b0055","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.jamda.2013.05.009","article-title":"Pro-inflammatory cytokines, aging, and age-related diseases","volume":"14","author":"Michaud","year":"2013","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.drudis.2022.103355_b0060","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.molmed.2020.02.008","article-title":"COVID-19: epidemiology, evolution, and cross-disciplinary perspectives","volume":"26","author":"Sun","year":"2020","journal-title":"Trends Mol Med"},{"key":"10.1016\/j.drudis.2022.103355_b0065","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1001\/jama.2020.2565","article-title":"Presumed asymptomatic carrier transmission of COVID-19","volume":"323","author":"Bai","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.drudis.2022.103355_b0070","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S1473-3099(20)30141-9","article-title":"Convalescent plasma as a potential therapy for COVID-19","volume":"20","author":"Chen","year":"2020","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.drudis.2022.103355_b0075","unstructured":"WHO. Clinical Management of Severe Acute Respiratory Infection (SARI) when COVID-19 Disease Is Suspected. www.who.int\/publications-detail\/infection-prevention-and-control-during-health-care-when-novel-coronavirus-(ncov)-infection-is-suspected-20200125 [Accessed September 7, 2022]."},{"key":"10.1016\/j.drudis.2022.103355_b0080","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.3389\/fimmu.2020.01022","article-title":"Highlight of immune pathogenic response and hematopathologic effect in SARS-CoV, MERS-CoV, and SARS-Cov-2 infection","volume":"11","author":"Liang","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2022.103355_b0085","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.cca.2020.06.017","article-title":"Cytokine storm induced by SARS-CoV-2","volume":"509","author":"Song","year":"2020","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.drudis.2022.103355_b0090","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.3389\/fimmu.2020.574862","article-title":"Mast cells in alveolar septa of COVID-19 patients: a pathogenic pathway that may link interstitial edema to immunothrombosis","volume":"11","author":"Motta Junior","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2022.103355_b0095","doi-asserted-by":"crossref","first-page":"846","DOI":"10.3389\/fimmu.2017.00846","article-title":"The mast cell, contact, and coagulation system connection in anaphylaxis","volume":"8","author":"Guilarte","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2022.103355_b0100","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/s41591-020-0822-7","article-title":"Estimating clinical severity of COVID-19 from the transmission dynamics in Wuhan","volume":"26","author":"Wu","year":"2020","journal-title":"China Nature Medicine"},{"key":"10.1016\/j.drudis.2022.103355_b0105","unstructured":"WHO. Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. www.who.int\/publications-detail\/infection-prevention-and-control-during-health-care-when-novel-coronavirus-(ncov)-infection-is-suspected-20200125."},{"key":"10.1016\/j.drudis.2022.103355_b0110","article-title":"The role of phylogenetic analysis in clarifying the infection source of a COVID-19 patient","author":"Wang","year":"2020","journal-title":"J Infect Published online"},{"key":"10.1016\/j.drudis.2022.103355_b0115","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1128\/MMBR.05015-11","article-title":"Into the eye of the cytokine storm","volume":"76","author":"Tisoncik","year":"2012","journal-title":"Microbiol Mol Biol Rev"},{"key":"10.1016\/j.drudis.2022.103355_b0120","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1080\/21645515.2020.1735227","article-title":"COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics","volume":"16","author":"Dhama","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.drudis.2022.103355_b0125","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.eng.2020.03.007","article-title":"Experimental treatment with favipiravir for COVID-19: an open-label control study","volume":"6","author":"Cai","year":"2020","journal-title":"Engineering"},{"key":"10.1016\/j.drudis.2022.103355_b0130","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir\u2013ritonavir in adults hospitalized with severe Covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.drudis.2022.103355_b0135","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.2147\/IDR.S258639","article-title":"Role of monocytes\/macrophages in Covid-19 pathogenesis: implications for therapy","volume":"13","author":"G\u00f3mez-Rial","year":"2020","journal-title":"Infection and Drug Resistance"},{"key":"10.1016\/j.drudis.2022.103355_b0140","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/S1499-3872(14)60024-2","article-title":"Inflammatory response of macrophages in infection","volume":"13","author":"Zhang","year":"2014","journal-title":"Hepatobiliary & Pancreatic Diseases International"},{"key":"10.1016\/j.drudis.2022.103355_b0145","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.addr.2019.12.001","article-title":"Drug delivery to macrophages: a review of targeting drugs and drug carriers to macrophages for inflammatory diseases","volume":"165\u2013166","author":"He","year":"2020","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.drudis.2022.103355_b0150","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.coph.2015.09.007","article-title":"Re-programming of macrophages\u2014new opportunities for therapeutic targeting","volume":"26","author":"Schultze","year":"2016","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.drudis.2022.103355_b0155","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0080908","article-title":"Macrophage polarisation: an immunohistochemical approach for identifying M1 and M2 macrophages","volume":"8","author":"Barros","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.drudis.2022.103355_b0160","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1189\/jlb.1A0314-170R","article-title":"The chemotaxis of M1 and M2 macrophages is regulated by different chemokines","volume":"97","author":"Xuan","year":"2015","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.drudis.2022.103355_b0165","series-title":"Presumed asymptomatic carrier transmission of COVID-19","author":"Bai","year":"2020"},{"key":"10.1016\/j.drudis.2022.103355_b0170","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.3389\/fimmu.2020.02132","article-title":"Cytokine storm in COVID-19: \u2018when you come out of the storm, you won't be the same person who walked in\u2019","volume":"11","author":"Castelli","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2022.103355_b0175","doi-asserted-by":"crossref","first-page":"9591","DOI":"10.7150\/thno.47982","article-title":"Nanomedicine therapies modulating Macrophage dysfunction: a potential strategy to attenuate cytokine storms in severe infections","volume":"10","author":"Liu","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.drudis.2022.103355_b0180","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fimmu.2020.00218","article-title":"Targeting of hepatic macrophages by therapeutic nanoparticles","volume":"11","author":"Colino","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2022.103355_b0185","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1039\/C6CS00636A","article-title":"Cellular uptake of nanoparticles: journey inside the cell","volume":"46","author":"Behzadi","year":"2017","journal-title":"Chem Soc Rev"},{"key":"10.1016\/j.drudis.2022.103355_b0190","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a016980","article-title":"Exploiting endocytosis for nanomedicines","volume":"5","author":"Akinc","year":"2013","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.drudis.2022.103355_b0195","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.tips.2018.03.001","article-title":"Macrophage-targeted therapeutics for metabolic disease","volume":"39","author":"Peterson","year":"2018","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.drudis.2022.103355_b0200","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1021\/acs.nanolett.7b05263","article-title":"Macrophage-membrane-coated nanoparticles for tumor-targeted chemotherapy","volume":"18","author":"Zhang","year":"2018","journal-title":"Nano Lett"},{"key":"10.1016\/j.drudis.2022.103355_b0205","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nrneph.2016.156","article-title":"Nanomedicines for renal disease: current status and future applications","volume":"12","author":"Kamaly","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.drudis.2022.103355_b0210","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.semarthrit.2008.08.004","article-title":"The potential of liposomal drug delivery for the treatment of inflammatory arthritis","volume":"39","author":"Vanniasinghe","year":"2009","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.drudis.2022.103355_b0215","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.3390\/ijms19071953","article-title":"Targeting macrophages as a potential therapeutic intervention: impact on inflammatory diseases and cancer","volume":"19","author":"Ponzoni","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.drudis.2022.103355_b0220","doi-asserted-by":"crossref","first-page":"20200155","DOI":"10.1002\/VIW.20200155","article-title":"Nano-therapeutic strategies to target coronavirus","volume":"2","author":"Rauf","year":"2021","journal-title":"View"},{"key":"10.1016\/j.drudis.2022.103355_b0225","doi-asserted-by":"crossref","first-page":"7471","DOI":"10.1016\/j.biomaterials.2013.06.008","article-title":"Mannosylated bioreducible nanoparticle-mediated macrophage-specific TNF-\u03b1 RNA interference for IBD therapy","volume":"34","author":"Xiao","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.drudis.2022.103355_b0230","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.biomaterials.2015.05.028","article-title":"Macrophage repolarization with targeted alginate nanoparticles containing IL-10 plasmid DNA for the treatment of experimental arthritis","volume":"61","author":"Jain","year":"2015","journal-title":"Biomaterials"},{"key":"10.1016\/j.drudis.2022.103355_b0235","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1021\/ar200044b","article-title":"Surface-engineered magnetic nanoparticle platforms for cancer imaging and therapy","volume":"44","author":"Xie","year":"2011","journal-title":"Acc Chem Res"},{"key":"10.1016\/j.drudis.2022.103355_b0240","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/j.drudis.2017.04.008","article-title":"Next-generation superparamagnetic iron oxide nanoparticles for cancer theranostics","volume":"22","author":"Li","year":"2017","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.drudis.2022.103355_b0245","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41568-021-00363-z","article-title":"Interleukins in cancer: from biology to therapy","volume":"21","author":"Briukhovetska","year":"2021","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.drudis.2022.103355_b0250","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.3389\/fimmu.2019.01998","article-title":"Nanoparticles targeting macrophages as potential clinical therapeutic agents against cancer and inflammation","volume":"10","author":"Hu","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2022.103355_b0255","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.pharmthera.2017.02.020","article-title":"Exosomes: therapy delivery tools and biomarkers of diseases","volume":"174","author":"Barile","year":"2017","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.drudis.2022.103355_b0260","doi-asserted-by":"crossref","first-page":"9361","DOI":"10.1016\/j.vaccine.2011.09.133","article-title":"Increasing vaccine potency through exosome antigen targeting","volume":"29","author":"Hartman","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.drudis.2022.103355_b0265","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1002\/bies.201100076","article-title":"Exosome nanotechnology: an emerging paradigm shift in drug delivery","volume":"33","author":"Lakhal","year":"2011","journal-title":"BioEssays"},{"key":"10.1016\/j.drudis.2022.103355_b0270","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12951-018-0403-9","article-title":"Recent advancements in the use of exosomes as drug delivery systems","volume":"16","author":"Bunggulawa","year":"2018","journal-title":"J Nanobiotechnology"},{"key":"10.1016\/j.drudis.2022.103355_b0275","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.3389\/fphys.2021.752287","article-title":"Extracellular vesicles and alveolar epithelial-capillary barrier disruption in acute respiratory distress syndrome: pathophysiological role and therapeutic potential","volume":"12","author":"Esquivel-Ruiz","year":"2021","journal-title":"Front Physiol"},{"key":"10.1016\/j.drudis.2022.103355_b0280","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/JLB.3MR0321-545RR","article-title":"Effects of mesenchymal stromal cell-derived extracellular vesicles in acute respiratory distress syndrome (ARDS): current understanding and future perspectives","volume":"110","author":"Su","year":"2021","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.drudis.2022.103355_b0285","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13287-018-0774-8","article-title":"Mesenchymal stem cell-derived extracellular vesicles attenuate influenza virus-induced acute lung injury in a pig model","volume":"9","author":"Khatri","year":"2018","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.drudis.2022.103355_b0290","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1186\/s13287-020-01937-8","article-title":"Mesenchymal stem cell-derived extracellular vesicles alter disease outcomes via endorsement of macrophage polarization","volume":"11","author":"Wang","year":"2020","journal-title":"Stem Cell Res Ther"},{"key":"10.1016\/j.drudis.2022.103355_b0295","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.768771","article-title":"Role of microRNA shuttled in small extracellular vesicles derived from mesenchymal stem\/stromal cells for osteoarticular disease treatment","volume":"12","author":"Lara-Barba","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.drudis.2022.103355_b0300","doi-asserted-by":"crossref","first-page":"7760","DOI":"10.1021\/acsnano.0c04006","article-title":"Nanotechnology for COVID-19: therapeutics and vaccine research","volume":"14","author":"Chauhan","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.drudis.2022.103355_b0305","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202000979","article-title":"Nanotechnology responses to COVID-19","volume":"9","author":"Ruiz-Hitzky","year":"2020","journal-title":"Adv Healthc Mater"},{"key":"10.1016\/j.drudis.2022.103355_b0310","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1128\/JVI.02052-06","article-title":"Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus","volume":"81","author":"Quan","year":"2007","journal-title":"J Virol"},{"key":"10.1016\/j.drudis.2022.103355_b0315","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1186\/1423-0127-21-34","article-title":"SARS-CoV envelope protein palmitoylation or nucleocapid association is not required for promoting virus-like particle production","volume":"21","author":"Tseng","year":"2014","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.drudis.2022.103355_b0320","series-title":"Recent Developments in Applied Microbiology and Biochemistry","first-page":"61","article-title":"Emerging trends in the development of plant virus-based nanoparticles and their biomedical applications","author":"Hema","year":"2019"},{"key":"10.1016\/j.drudis.2022.103355_b0325","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.jconrel.2013.04.023","article-title":"Infusion of imaging and therapeutic molecules into the plant virus-based carrier cowpea mosaic virus: cargo-loading and delivery","volume":"172","author":"Yildiz","year":"2013","journal-title":"J Control Release"}],"container-title":["Drug Discovery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644622003488?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1359644622003488?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T13:02:13Z","timestamp":1761224533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1359644622003488"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":65,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S1359644622003488"],"URL":"https:\/\/doi.org\/10.1016\/j.drudis.2022.103355","relation":{},"ISSN":["1359-6446"],"issn-type":[{"value":"1359-6446","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nanomedicine approaches to reduce cytokine storms in severe infections","name":"articletitle","label":"Article Title"},{"value":"Drug Discovery Today","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drudis.2022.103355","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103355"}}